Galmed Pharmaceuticals
GLMD
GLMD
18 hedge funds and large institutions have $3.56M invested in Galmed Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$65.7K | |
| 2 | +$49K | |
| 3 | +$10K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$7.04K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
+$1.79K |
Top Sellers
| 1 | -$242K | |
| 2 | -$223K | |
| 3 | -$88K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$23K |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$16K |